Safety and immunogenicity of COVID-19 vaccination among liver transplant recipients in China

Hepatobiliary Pancreat Dis Int. 2022 Dec;21(6):605-608. doi: 10.1016/j.hbpd.2022.06.010. Epub 2022 Jun 23.
No abstract available

Publication types

  • Letter

MeSH terms

  • COVID-19 / epidemiology
  • COVID-19 / prevention & control
  • COVID-19 Vaccines* / adverse effects
  • China / epidemiology
  • Humans
  • Liver Transplantation*
  • Transplant Recipients
  • Vaccination / adverse effects

Substances

  • COVID-19 Vaccines